Insider files Form 144: IBRX (NASDAQ: IBRX) plans sale of 159,478 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
The issuer reports a proposed resale of 159,478 common shares related to an exercise of stock options to be settled for cash on 07/01/2026. The filing also records recent 10b5-1 sales of 95,722 shares and 1,000 shares on 06/29/2026 and 06/30/2026, respectively, with proceeds shown.
Positive
- None.
Negative
- None.
Key Figures
Proposed resale: 159,478 shares
10b5-1 sale: 95,722 shares
10b5-1 sale: 1,000 shares
3 metrics
Proposed resale
159,478 shares
exercise of stock options, <date>07/01/2026</date>
10b5-1 sale
95,722 shares
sale on <date>06/29/2026</date>, proceeds $862,212.63
10b5-1 sale
1,000 shares
sale on <date>06/30/2026</date>, proceeds $9,000.00
Key Terms
Form 144, 10b5-1, Exercise of Stock Options
3 terms
Form 144 regulatory
"Notice of proposed sale of restricted or control securities"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"Listed as "10b5-1 Sales" for Christobel Selecky"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold — Exercise of Stock Options — Cash settlement"
FAQ
What does IBRX's Form 144 report?
It notifies a proposed sale of 159,478 shares. The filing ties that amount to an exercise of stock options with cash settlement on 07/01/2026. It also lists recent 10b5-1 sales of 95,722 and 1,000 shares on June 29 and 30, 2026.
Who executed recent 10b5-1 sales noted in the filing?
Christobel Selecky is named as the 10b5-1 seller for the two recent transactions. The filing shows sales of 95,722 shares for $862,212.63 and 1,000 shares for $9,000 on the dates provided.
How much cash did the recent 10b5-1 sales generate?
Combined proceeds shown total $871,212.63. The filing lists proceeds of $862,212.63 from the 95,722-share sale and $9,000.00 from the 1,000-share sale on the stated dates in June 2026.